Justin Head, DO
Orthopaedic Surgery · Phoenix, AZNPI 1598105140
Payments from drug & device makers
Across 60 payments — averaging $141.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Globus Medical$3K
- Johnson & Johnson$1K
- Smith+Nephew$449
- Corin USA$116
- Medical Device Business Services, Inc.$72
- plus $119 from 4 others
What the payments were for
- Travel & lodging$5,90370%
- Food & beverage$2,58730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 27 | $3,412 |
| Globus Medical | 10 | $3,151 |
| Johnson & Johnson | 6 | $1,171 |
| Smith+Nephew | 5 | $449 |
| Corin USA | 1 | $116 |
| Medical Device Business Services, Inc. | 4 | $72 |
| Amgen | 4 | $60 |
| Medacta USA, Inc. | 1 | $24 |
| Solventum Corporation | 1 | $21 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,404
- Joints - Prototype$1,519
- Legacy Stelkast Knee$736
- Genflex2 Total Knee System$572
- TRIATHLON$399
- Navio Surgical System$267
- REDAPT Revision Hip System$267
- Legion Revision$267
How this compares
$8,490 in reported general payments places this provider in the 60th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 138 | $2,203 |
| Diclofenac Sodium | 77 | $1,185 |
| Oxycodone Hcl | 160 | $1,130 |
| Ondansetron OdtOndansetron | 133 | $936 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 78 | $492 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $288 |
| Levofloxacin | 60 | $272 |
| Methylprednisolone | 20 | $148 |
| Tramadol Hcl | 44 | $133 |
| Gabapentin | 26 | $107 |
| Tamsulosin Hcl | 29 | $76 |
| Meloxicam | 35 | $63 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Phoenix
- Joseph GimbelPhoenix$19.4M
- Evan LedermanPhoenix$13.4M
- James ChowPhoenix$6.2M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$1.1M
- Maegen WallacePhoenix$832K
- Anthony HedleyPhoenix$417K
- Matthew SeidelPhoenix$397K
- David OttPhoenix$380K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.